Related Experiment Video
Updated: Jan 14, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Effect of Medium Cut-Off Dialyzers on Calcification Propensity in Hemodialysis Patients: A 6-Month Prospective Pilot
Berfu Korucu1, Joyce Xu2,3, Henrike Hamer3
1Department of Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Insights
Medium cut-off (MCO) dialyzers did not improve serum calcification propensity (T50) in hemodialysis patients compared to low-flux (LF) dialyzers. Enhanced clearance of uremic toxins by MCO dialyzers did not significantly impact T50 scores.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- T50 measures calcification propensity and predicts cardiovascular risk in hemodialysis (HD) patients.
- Cardiovascular disease in HD patients is linked to uremic toxins.
- Medium cut-off (MCO) dialyzers improve clearance of middle molecular weight (MW) uremic toxins over conventional dialyzers.
Purpose of the Study:
- To investigate the long-term impact of MCO dialyzers on pre- and post-dialysis T50 scores.
- To compare the efficacy of MCO versus low-flux (LF) dialyzers in improving T50.
- To assess the relationship between T50 and uremic toxin clearance.
Main Methods:
- Maintenance HD patients on LF dialyzers were studied.
- Pre- and post-dialysis serum samples were collected at baseline (LF) and 6 months after switching to MCO dialyzers.
- Changes in T50 were analyzed for single HD treatments, and pre-dialysis T50 scores were compared over time.
Main Results:
- Pre- and post-dialysis T50 improvement percentages were similar between LF and MCO dialyzers (p=0.35).
- Pre-dialysis T50 after 6 months on MCO was comparable to baseline (p=0.73).
- Baseline T50 inversely correlated with T50 improvement post-HD (p<0.01), and smoking was associated with higher pre-dialysis T50 on MCO (p=0.02).
Conclusions:
- MCO dialyzers offer no additional benefit over LF dialyzers in improving serum calcification propensity (T50).
- The removal of middle MW uremic toxins by MCO dialyzers does not significantly contribute to changes in T50 scores.
- Current evidence does not support MCO dialyzers for improving T50 in HD patients.
Background:
T50 is a serum-based measure of calcification propensity and a predictor of cardiovascular risk and mortality in hemodialysis (HD) patients. Cardiovascular disease is in part driven by uremic toxins. Medium cut-off (MCO) dialyzers enhance the clearance of middle molecular weight (MW) uremic toxins compared to conventional dialyzers. However, the long-term impact of MCO dialyzers on pre-dialysis and post-dialysis T50 scores remains unknown.
Methods:
The study included maintenance HD patients on low-flux (LF) dialyzers. Pre- and post-dialysis serum samples were collected in mid-week HD sessions: first with LF dialyzers (baseline) and then 6 months after switching to MCO dialyzers. Change in T50 was analyzed for a single HD treatment under LF and MCO dialyzers, and baseline and sixth-month pre-dialysis T50 scores were compared.
Results:
Fifteen patients were included. Pre- and post-dialysis percent improvement in T50 for LF and MCO dialyzers were similar (85.2% [45.0, 282.7] and 56.3% [21.1, 238.6], respectively, p = 0.35). Pre-dialysis T50 after 6 months on MCO was comparable to the baseline (p = 0.73). Pre-dialysis T50 at baseline had an inverse association with improvement in T50 after a single HD treatment (β = -0.88; 95% CI: -1.18 to -0.57; p < 0.01), and smoking had a direct association with pre-dialysis T50 after 6 months of MCO treatment (β = -172; 95% CI: -287 to -56.8; p = 0.02).
Conclusion:
MCO dialyzers do not confer additional benefits in improving serum calcification propensity, compared to LF dialyzers. Our data do not support a significant contribution of middle MW uremic toxins' removal to T50 scores.
Related Concept Videos
Dialysis
Hemodialysis II: Procedure and Complications
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction

